In vitro and in vivo studies have revealed the oncogenic role of NAA10 in lung cancer, demonstrating that NAA10 binds to DNMT1 and positively regulates its enzymatic activity by facilitating DNMT1′s binding to DNA and its recruitment to the promoters of tumor suppressor genes, such as E-cadherin [56]. This evidence concerns the gene DNMT1 and lung cancer.